FDA approval of Omontys changes the ESA playing field.
Mark E
ME
Neumann
D000740:Anemia / Q000188:drug therapy* / Q000209:etiology; D017277:Drug Approval; D004345:Drug Industry / Q000639:trends*; D006397:Hematinics / Q000627:therapeutic use*; D006801:Humans; D007676:Kidney Failure, Chronic / Q000150:complications / Q000628:therapy*; D006435:Renal Dialysis; D014481:United States
D006397:Hematinics